Queenan Daniel G

CEO Queenan sells 10,000 CBRE shares at $140.12; holds 207,094 post-sale as stock near 52-week high

On 2024-12-02, Queenan Daniel G, CEO of Real Estate Investments at CBRE, sold 10,000 shares at $140.12 for $1,401,200, reducing his holdings from 217,094 to 207,094 shares (a -4.6% reduction). The transaction occurred near the stock's 52-week high of $140.71, with the current price at $137.75. Across his cross-ticker history, Queenan's two prior sales averaged +25.3% returns in the subsequent 90-day period, indicating his sell-timing has been poorly aligned with subsequent gains. At CBRE specifically, both prior sales (2024-09-03 and 2024-06-03) also yielded positive 90-day returns of +20.7% and +29.9% respectively, showing a consistent pattern of selling before the stock advanced rather than declining. The company's P/E of 44.01 sits above historical context, and the sale represents a discrete disposal of a subset position rather than a material reduction in CEO shareholding levels.

CBRE CEO Daniel G Queenan sold 10,000 shares at $114.67 on 2024-09-03; stock now at $114.15.

CEO Daniel G Queenan sold 10,000 shares for $1,146,700.00, reducing his holdings by 4.4% to 217,094 shares post-transaction. The sale occurred near the 52-week high of $117.03, with CBRE trading at $114.15 today (2.5% below the high). Across his cross-ticker trading history, Queenan's prior open-market sales averaged 90-day returns of +29.9%, with a 90-day well-timed rate of 0.00%, indicating his prior sells have not preceded stock declines. At CBRE specifically, his prior 2024-06-03 sale similarly showed poor timing at the 90-day mark, with the stock up 29.9% afterward. The company trades at a P/E of 37.92 with recent revenue growth of 3.6% and quarterly net income of $130,000,000.00 on $8,391,000,000.00 in quarterly revenue. This sale represents a moderate-size reduction in executive holdings rather than a substantial stake reduction, and the timing relative to recent price momentum does not align with a pattern of prescient selling.